WGS

New York, New York--(Newsfile Corp. - July 9, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired GeneDx securities between April 16, 2025 and May 4, 2026, both dates inclusive (the "Class Period").

NEW YORK--(BUSINESS WIRE)--Levi & Korsinsky, LLP highlights the contrast between GeneDx Holdings Corp.'s (NASDAQ: WGS) promises to investors and the actual results of its Fabric Genomics acquisition. Shareholders who purchased WGS securities between April 16, 2025 and May 4, 2026 and suffered losses may be entitled to compensation. Find out if you can recover your investment losses or contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500. On May 5, 2026, WGS shares close.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In GeneDx To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in GeneDx between April 16, 2025 and May 4, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - July 9, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against GeneDx Holdings Corp. ("GeneDx" or the "Company") (NASDAQ: WGS) and reminds investors of the August 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Did you buy WGS securities between April 16, 2025, and May 4, 2026? Affected WGS Investor Summary Who: GeneDx Holdings Corp. (NASDAQ: WGS) What: Securities fraud class action lawsuit filed Class Period: April 16, 2025 through May 4, 2026 Deadline to Seek Lead Plaintiff Status: August 3, 2026 Key Lawsuit Allegations: Material misstatements and/or omissions concerning the viability of the company's acquisition of Fabric Genomics Investor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options RADNOR, Pa.

LOS ANGELES, July 09, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against GeneDx Holdings Corp. (“GeneDx” or “the Company”) (NASDAQ: WGS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), are encouraged to contact the firm before August 3, 2026.

NEW YORK, July 09, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds GeneDx Holdings Corp. (“WGS” or the “Company”) (NASDAQ: WGS) investors of the August 3, 2026 deadline involving a securities fraud class action lawsuit commenced against the Company. Should You Join The GeneDx Holdings Class Action Lawsuit : Do you, or did you, own shares of GeneDx Holdings Corp. (NASDAQ: WGS)?

SAN FRANCISCO, July 9, 2026 /PRNewswire/ -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential. The suit follows a devastating 49% stock collapse on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report, including a $31.2 million impairment charge.

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.

New York, New York and New Orleans, Louisiana--(Newsfile Corp. - July 8, 2026) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until August 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) ("GeneDx" or the "Company"), if they purchased or otherwise acquired the Company's shares between April 16, 2025 and May 4, 2026, inclusive (the "Class Period").

SAN FRANCISCO, July 08, 2026 (GLOBE NEWSWIRE) -- Hagens Berman (HBSS), a national leader in securities litigation, is actively investigating claims in a securities class action lawsuit against GeneDx Holdings (NASDAQ: WGS) and its executives, alleging defendants misled investors about the Fabric Genomics acquisition and synergy potential. The suit follows a devastating 49% stock collapse on May 5, 2026 in response to the company's disastrous Q1 2026 earnings report, including a $31.2 million impairment charge.